Which block eases pain after prostate surgery? study compares two options
NCT ID NCT06975735
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested two types of nerve blocks—the transversalis fascia plane (TFP) block and the transversus abdominis plane (TAP) block—to see which one works better for pain relief after robotic-assisted partial prostatectomy. 108 men received one of the blocks with bupivacaine, and researchers measured how long it took before they needed more pain medicine. The goal was to find which block reduces pain, speeds recovery, and shortens hospital stays.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If one block works better, it could lead to less pain and faster recovery after robotic prostate surgery.
- What could go wrong
- This is a small, completed study with 108 participants, so results may not apply to all patients. Both blocks are already in use, so no major breakthrough is expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kudret Doğru
Kayseri, Melikgazi, 38050, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Parkinson's pain: could a new Add-On drug bring relief?